361 research outputs found
Plasmid encoding matrix protein of vesicular stomatitis viruses as an antitumor agent inhibiting rat glioma growth in situ
Aim: Oncolytic effect of vesicular stomatitis virus (VSV) has been proved previously. Aim of the study is to investigate glioma inhibition effect of Matrix (M) protein of VSV in situ. Materials and Methods: A recombinant plasmid encoding VSV M protein (PM) was genetically engineered, and then transfected into cultured C6 gliomas cells in vitro. C6 transfected with Liposome-encapsulated PM (LEPM) was implanted intracranially for tumorigenicity study. In treatment experiment, rats were sequentially established intracranial gliomas with wild-typed C6 cells, and accepted LEPM injection intravenously. Possible mechanism of M protein was studied by using Hoechst staining, PI-stained flow cytometric analysis, TUNEL staining and CD31 staining. Results: M protein can induce generous gliomas lysis in vitro. None of the rats implanted with LEPM-treated cells developed any significant tumors, whereas all rats in control group developed tumors. In treatment experiment, smaller tumor volume and prolonged survival time was found in the LEPM-treated group. Histological studies revealed that possible mechanism were apoptosis and anti-angiogenesis. Conclusion: VSV-M protein can inhibit gliomas growth in vitro and in situ, which indicates such a potential novel biotherapeutic strategy for glioma treatment.Π¦Π΅Π»Ρ: ΠΈΠ·ΡΡΠΈΡΡ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΠΈΠ½Π° (Π ΠΏΡΠΎΡΠ΅ΠΈΠ½Π°) Π²ΠΈΡΡΡΠ° Π²Π΅Π·ΠΈΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΡΡΠΎΠΌΠ°ΡΠΈΡΠ° (ΠΠΠ‘) ΡΠ³Π½Π΅ΡΠ°ΡΡ ΡΠΎΡΡ Π³Π»ΠΈΠΎΠΌΡ
in situ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ: ΡΠΊΠΎΠ½ΡΡΡΡΠΈΡΠΎΠ²Π°Π½Π° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½Π°Ρ ΠΏΠ»Π°Π·ΠΌΠΈΠ΄Π°, ΠΊΠΎΠ΄ΠΈΡΡΡΡΠ°Ρ Π ΠΏΡΠΎΡΠ΅ΠΈΠ½ ΠΠΠ‘, ΠΊΠΎΡΠΎΡΠ°Ρ Π·Π°ΡΠ΅ΠΌ Π±ΡΠ»Π°
ΡΡΠ°Π½ΡΡΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π° Π² ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ Π³Π»ΠΈΠΎΠΌΡ Π‘6 in. ΠΠ»Π΅ΡΠΊΠΈ Π³Π»ΠΈΠΎΠΌΡ Π‘6, ΡΡΠ°Π½ΡΡΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΈΠ½ΠΊΠ°ΠΏΡΡΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ
Π² Π»ΠΈΠΏΠΎΡΠΎΠΌΡ Π ΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠΌ (ΠΠΠΠ), ΠΈΠΌΠΏΠ»Π°Π½ΡΠΈΡΠΎΠ²Π°Π»ΠΈ ΠΈΠ½ΡΡΠ°ΠΊΡΠ°Π½ΠΈΠ°Π»ΡΠ½ΠΎ Π΄Π»Ρ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΡΡΠΌΠΎΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ. Π ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ΅ ΠΊΡΡΡΠ°ΠΌ
Ρ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΈΠ½ΡΡΠ°ΠΊΡΠ°Π½ΠΈΠ°Π»ΡΠ½ΠΎ Π³Π»ΠΈΠΎΠΌΠΎΠΉ Π‘6 (ΠΈΡΡ
ΠΎΠ΄Π½ΡΠΉ ΡΡΠ°ΠΌΠΌ) Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎ Π²Π²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΠΠΠ. ΠΠΏΠΎΠΏΡΠΎΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅
Π ΠΏΡΠΎΡΠ΅ΠΈΠ½Π° Π½Π° ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ ΠΈΠ·ΡΡΠ°Π»ΠΈ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠ΅Π½ΡΠ½ΠΎΠΉ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΠΈ (ΠΎΠΊΡΠ°ΡΠΈΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎ Π₯Π΅Ρ
ΡΡΡ),
ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ (ΠΎΠΊΡΠ°ΡΠΈΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΠΏΠΈΠ΄ΠΈΡΠΌΠΎΠΌ ΠΉΠΎΠ΄ΠΈΠ΄ΠΎΠΌ), TUNEL Π²Π°ΡΠΊΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ ΠΈ Π²Π°ΡΠΊΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ ΠΈ
ΠΈΠΌΠΌΡΠ½ΠΎΠ³ΠΈΡΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ Π°Π½ΡΠΈ-CD31 ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π°Π½ΡΠΈΡΠ΅Π». 31 ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π°Π½ΡΠΈΡΠ΅Π». 31 ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π°Π½ΡΠΈΡΠ΅Π». Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ: Π ΠΏΡΠΎΡΠ΅ΠΈΠ½ ΠΌΠΎΠΆΠ΅Ρ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°ΡΡ
Π»ΠΈΠ·ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ Π³Π»ΠΈΠΎΠΌΡ in. ΠΠΈ Ρ ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΆΠΈΠ²ΠΎΡΠ½ΠΎΠ³ΠΎ Ρ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ Π³Π»ΠΈΠΎΠΌΡ, ΠΎΠ±ΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΠΌΠΈ ΠΠΠΠ,
Π½Π΅ Π²ΠΎΠ·Π½ΠΈΠΊΠ°Π»ΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ°Π·ΠΌΠ΅ΡΠ°, ΡΠΎΠ³Π΄Π° ΠΊΠ°ΠΊ Ρ Π²ΡΠ΅Ρ
ΠΊΡΡΡ ΠΈΠ· ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΡΠ°Π·Π²ΠΈΠ²Π°Π»ΠΈΡΡ. Π Π³ΡΡΠΏΠΏΠ΅
ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
, ΠΊΠΎΡΠΎΡΡΠΌ Π²Π²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΠΠΠ, ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π±ΡΠ»ΠΈ ΠΌΠ΅Π½ΡΡΠ΅Π³ΠΎ ΠΎΠ±ΡΠ΅ΠΌΠ° ΠΈ ΠΎΡΠΌΠ΅ΡΠ°Π»ΠΈ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΆΠΈΠ·Π½ΠΈ
ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π ΠΏΡΠΎΡΠ΅ΠΈΠ½ ΠΏΡΠΎΡΠ²Π»ΡΠ΅Ρ Π°Π½ΡΠΈΠ°Π½Π³ΠΈΠΎΠ³Π΅Π½Π½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΠΈ ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡΡ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°ΡΡ Π°ΠΏΠΎΠΏΡΠΎΠ·.
ΠΡΠ²ΠΎΠ΄Ρ: Π ΠΏΡΠΎΡΠ΅ΠΈΠ½ ΠΠΠ‘ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΡΠ΅Ρ ΡΠΎΡΡ Π³Π»ΠΈΠΎΠΌΡ in ΠΈ in. ΠΠ° ΡΡΠΎΠΉ ΠΎΡΠ½ΠΎΠ²Π΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ Π½ΠΎΠ²Π°Ρ
Π±ΠΈΠΎΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡ Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³Π»ΠΈΠΎΠΌΠ°ΠΌΠΈ
Transcriptome analysis of hepatic gene expression and DNA methylation in methionine- and betaine-supplemented geese (Anser cygnoides domesticus)
Dietary methionine (Met) restriction produces a coordinated series of transcriptional responses in the liver that limits growth performance and amino acid metabolism. Methyl donor supplementation with betaine (Bet) may protect against this disturbance and affect the molecular basis of gene regulation. However, a lack of genetic information remains an obstacle to understand the mechanisms underlying the relationship between Met and Bet supplementation and its effects on genetic mechanisms. The goal of this study was to identify the effects of dietary supplementation of Met and Bet on growth performance, transcriptomic gene expression, and epigenetic mechanisms in geese on a Met-deficient diet. One hundred and fifty 21-day-old healthy male Yangzhou geese of similar body weight were randomly distributed into 3 groups with 5 replicates per treatment and 10 geese per replicate: Met-deficient diet (Control), Control+1.2 g/kg of Met (Met), and Control+0.6 g/kg of Bet (Bet). All geese had free access to the diet and water throughout rearing. Our results indicated that supplementation of 1.2 g/kg of Met in Met-deficient feed increased growth performance and plasma homocysteine (HCY) levels, indicating increased transsulfuration flux in the liver. Supplementation of 0.6 g/kg Bet had no apparent sparing effect on Met needs for growth performance in growing geese. The expression of many genes critical for Met metabolism is increased in Met supplementation group. In the Bet-supplemented group, genes involved in energy production and conversion were up-regulated. Dietary supplementation with Bet and Met also altered DNA methylation. We observed changes in the methylation of the LOC106032502 promoter and corresponding changes in mRNA expression. In conclusion, Met and Bet supplementation in geese affects the transcriptional regulatory network and alters the hepatic DNA methylation of LOC106032502
Observation of Two New N* Peaks in J/psi -> and Decays
The system in decays of is limited to be
isospin 1/2 by isospin conservation. This provides a big advantage in studying
compared with and experiments which mix
isospin 1/2 and 3/2 for the system. Using 58 million decays
collected with the Beijing Electron Positron Collider, more than 100 thousand
events are obtained. Besides two well known
peaks at 1500 MeV and 1670 MeV, there are two new, clear peaks in
the invariant mass spectrum around 1360 MeV and 2030 MeV. They are the
first direct observation of the peak and a long-sought "missing"
peak above 2 GeV in the invariant mass spectrum. A simple
Breit-Wigner fit gives the mass and width for the peak as MeV and MeV, and for the new peak above 2 GeV
as MeV and MeV, respectively
Multiple-path Quantum Interference Effects in a Double-Aharonov-Bohm Interferometer
We investigate quantum interference effects in a double-Aharonov-Bohm (AB) interferometer consisting of five quantum dots sandwiched between two metallic electrodes in the case of symmetric dot-electrode couplings by the use of the Greenβs function equation of motion method. The analytical expression for the linear conductance at zero temperature is derived to interpret numerical results. A three-peak structure in the linear conductance spectrum may evolve into a double-peak structure, and two Fano dips (zero conductance points) may appear in the quantum system when the energy levels of quantum dots in arms are not aligned with one another. The AB oscillation for the magnetic flux threading the double-AB interferometer is also investigated in this paper. Our results show the period of AB oscillation can be converted from 2Ο to Ο by controlling the difference of the magnetic fluxes threading the two quantum rings
Spin-filtering and charge- and spin-switching effects in a quantum wire with periodically attached stubs
Spin-dependent electron transport in a periodically stubbed quantum wire in
the presence of Rashba spin-orbit interaction (SOI) is studied via the
nonequilibrium Green's function method combined with the Landauer-Buttiker
formalism. The coexistence of spin filtering, charge and spin switching are
found in the considered system. The mechanism of these transport properties is
revealed by analyzing the total charge density and spin-polarized density
distributions in the stubbed quantum wire. Furthermore, periodic spin-density
islands with high polarization are also found inside the stubs, owing to the
interaction between the charge density islands and the Rashba SOI-induced
effective magnetic field. The proposed nanostructure may be utilized to devise
an all-electrical multifunctional spintronic device.Comment: 4 pages, 4 figure
Direct Measurements of the Branching Fractions for and and Determinations of the Form Factors and
The absolute branching fractions for the decays and
are determined using singly
tagged sample from the data collected around 3.773 GeV with the
BES-II detector at the BEPC. In the system recoiling against the singly tagged
meson, events for and events for decays are observed. Those yield
the absolute branching fractions to be and . The
vector form factors are determined to be
and . The ratio of the two form
factors is measured to be .Comment: 6 pages, 5 figure
Measurements of J/psi Decays into 2(pi+pi-)eta and 3(pi+pi-)eta
Based on a sample of 5.8X 10^7 J/psi events taken with the BESII detector,
the branching fractions of J/psi--> 2(pi+pi-)eta and J/psi-->3(pi+pi-)eta are
measured for the first time to be (2.26+-0.08+-0.27)X10^{-3} and
(7.24+-0.96+-1.11)X10^{-4}, respectively.Comment: 11 pages, 6 figure
BESII Detector Simulation
A Monte Carlo program based on Geant3 has been developed for BESII detector
simulation. The organization of the program is outlined, and the digitization
procedure for simulating the response of various sub-detectors is described.
Comparisons with data show that the performance of the program is generally
satisfactory.Comment: 17 pages, 14 figures, uses elsart.cls, to be submitted to NIM
Measurement of branching fractions for the inclusive Cabibbo-favored ~K*0(892) and Cabibbo-suppressed K*0(892) decays of neutral and charged D mesons
The branching fractions for the inclusive Cabibbo-favored ~K*0 and
Cabibbo-suppressed K*0 decays of D mesons are measured based on a data sample
of 33 pb-1 collected at and around the center-of-mass energy of 3.773 GeV with
the BES-II detector at the BEPC collider. The branching fractions for the
decays D+(0) -> ~K*0(892)X and D0 -> K*0(892)X are determined to be BF(D0 ->
\~K*0X) = (8.7 +/- 4.0 +/- 1.2)%, BF(D+ -> ~K*0X) = (23.2 +/- 4.5 +/- 3.0)% and
BF(D0 -> K*0X) = (2.8 +/- 1.2 +/- 0.4)%. An upper limit on the branching
fraction at 90% C.L. for the decay D+ -> K*0(892)X is set to be BF(D+ -> K*0X)
< 6.6%
- β¦